Evercore ISI Boosts Intuitive Surgical (NASDAQ:ISRG) Price Target to $490.00

by · The Cerbat Gem

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its price objective raised by equities research analysts at Evercore ISI from $475.00 to $490.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has an “in-line” rating on the medical equipment provider’s stock. Evercore ISI’s target price indicates a potential downside of 5.51% from the stock’s current price.

Several other research analysts have also recently commented on the company. BTIG Research upped their price target on Intuitive Surgical from $494.00 to $518.00 and gave the stock a “buy” rating in a report on Monday. Stifel Nicolaus raised their price target on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research note on Friday. Leerink Partners raised their target price on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday. Mizuho raised their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday. Finally, Morgan Stanley raised their price target on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $497.70.

View Our Latest Stock Analysis on ISRG

Intuitive Surgical Trading Up 9.5 %

ISRG stock traded up $44.86 during midday trading on Friday, reaching $518.59. The stock had a trading volume of 2,430,883 shares, compared to its average volume of 1,470,179. Intuitive Surgical has a 52-week low of $254.85 and a 52-week high of $519.54. The company has a market cap of $183.94 billion, a price-to-earnings ratio of 93.43, a price-to-earnings-growth ratio of 5.40 and a beta of 1.39. The company’s fifty day simple moving average is $482.69 and its 200 day simple moving average is $436.91.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company had revenue of $2.01 billion during the quarter, compared to analyst estimates of $1.97 billion. During the same quarter last year, the firm posted $1.18 earnings per share. Intuitive Surgical’s revenue was up 14.5% compared to the same quarter last year. Sell-side analysts predict that Intuitive Surgical will post 5.22 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, Director Amal M. Johnson sold 2,943 shares of the company’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at $5,441,507.50. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the sale, the director now directly owns 821 shares in the company, valued at $402,519.88. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Amal M. Johnson sold 2,943 shares of the stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $5,441,507.50. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 53,120 shares of company stock worth $25,528,753 in the last quarter. Insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its position in Intuitive Surgical by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock valued at $12,319,358,000 after buying an additional 493,126 shares in the last quarter. Capital World Investors boosted its stake in Intuitive Surgical by 1.0% during the 1st quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock valued at $2,907,079,000 after purchasing an additional 73,634 shares during the last quarter. Jennison Associates LLC increased its holdings in Intuitive Surgical by 4.6% in the 1st quarter. Jennison Associates LLC now owns 4,488,343 shares of the medical equipment provider’s stock worth $1,791,253,000 after buying an additional 198,483 shares in the last quarter. American Century Companies Inc. boosted its holdings in shares of Intuitive Surgical by 3.0% during the 2nd quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock valued at $1,066,837,000 after acquiring an additional 70,556 shares during the last quarter. Finally, Clearbridge Investments LLC boosted its position in Intuitive Surgical by 1.6% in the second quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider’s stock worth $881,380,000 after purchasing an additional 30,449 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading